{"id":"desloratadine-clarinex","safety":{"commonSideEffects":[{"rate":"12-15","effect":"Headache"},{"rate":"2-3","effect":"Somnolence"},{"rate":"2-3","effect":"Fatigue"},{"rate":"1-2","effect":"Dry mouth"},{"rate":"1-2","effect":"Pharyngitis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Desloratadine competitively binds to peripheral H1 receptors on mast cells and basophils, preventing histamine release and its downstream effects on smooth muscle contraction, vasodilation, and itching. As a non-sedating antihistamine, it has minimal blood-brain barrier penetration due to its molecular structure and substrate for efflux transporters, making it suitable for daytime use in allergic conditions.","oneSentence":"Desloratadine is a selective histamine H1-receptor antagonist that blocks histamine-mediated allergic responses without significant central nervous system penetration.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:09:06.133Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic rhinitis (seasonal and perennial)"},{"name":"Chronic idiopathic urticaria"}]},"trialDetails":[{"nctId":"NCT07486583","phase":"PHASE3","title":"Autologous Whole Blood Therapy in Chronic Idiopathic Urticaria Patients.","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-04-30","conditions":"Chronic Idiopathic Urticaria","enrollment":40},{"nctId":"NCT07109817","phase":"PHASE2","title":"Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2026-03","conditions":"Breast Cancer, Peripheral Neuropathy","enrollment":116},{"nctId":"NCT07333716","phase":"PHASE2","title":"Desloratadine in Patients With Ulcerative Colitis","status":"RECRUITING","sponsor":"Tanta University","startDate":"2026-01-26","conditions":"Ulcerative Colitis (UC), Ulcerative Colitis","enrollment":44},{"nctId":"NCT05232825","phase":"PHASE3","title":"A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2022-05-03","conditions":"Relapsing Multiple Sclerosis, Primary Progressive Multiple Sclerosis","enrollment":236},{"nctId":"NCT05042830","phase":"NA","title":"Contribution of Nasal IgE Production to the Boost of Systemic Allergen-specific IgE Upon Nasal Allergen Contact","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2021-11-11","conditions":"Allergy","enrollment":30},{"nctId":"NCT05214911","phase":"PHASE3","title":"Fixed Dose Combination of Desloratadine / Prednisolone in the Treatment of Moderate Severe Allergic Rhinitis in Children","status":"COMPLETED","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2024-07-08","conditions":"Allergic Rhinitis","enrollment":262},{"nctId":"NCT06916884","phase":"PHASE3","title":"Confirmatory Study on the Efficacy and Safety of the Fixed-dose Combination of Desloratadine/Betamethasone Versus Desloratadine","status":"RECRUITING","sponsor":"Laboratorios Silanes S.A. de C.V.","startDate":"2024-11-11","conditions":"Allergic Rhinitis","enrollment":70},{"nctId":"NCT06806826","phase":"PHASE4","title":"The Effect of Omalizumab on Allergic Rhinitis Symptoms: a Comparative Study","status":"COMPLETED","sponsor":"Yuzuncu Yil University","startDate":"2019-01-01","conditions":"Allergic Rhinitis","enrollment":50},{"nctId":"NCT00783211","phase":"PHASE4","title":"Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR)(Study P04053)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-08-01","conditions":"Seasonal Allergic Rhinitis","enrollment":722},{"nctId":"NCT00867191","phase":"PHASE4","title":"Comparison of the Effects of Desloratadine and Placebo in the Relief of Nasal Symptom Scores in Subjects With Seasonal Allergic Rhinitis to Cypress Pollen (Study P02836)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-02-01","conditions":"Seasonal Allergic Rhinitis","enrollment":233},{"nctId":"NCT00789152","phase":"PHASE3","title":"The Effect of Desloratadine and Levocetirizine on Nasal Obstruction (Study P03609)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-12-01","conditions":"Allergic Rhinitis","enrollment":81},{"nctId":"NCT00783354","phase":"PHASE4","title":"A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-04-01","conditions":"Urticaria, Chronic Idiopathic Urticaria","enrollment":129},{"nctId":"NCT00757562","phase":"PHASE3","title":"Safety of Desloratadine in Children With Allergy Sensitivity and Chronic Hives, Who Are Poor Metabolizers of Desloratadine (Study P02994)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-11-01","conditions":"Chronic Idiopathic Urticaria, Atopy","enrollment":97},{"nctId":"NCT00783133","phase":"PHASE4","title":"Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03177)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-11-01","conditions":"Seasonal Allergic Rhinitis","enrollment":131},{"nctId":"NCT00751218","phase":"PHASE4","title":"A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03735)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-05-06","conditions":"Urticaria","enrollment":174},{"nctId":"NCT00751166","phase":"PHASE4","title":"A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03736)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2004-03-01","conditions":"Urticaria","enrollment":149},{"nctId":"NCT00783146","phase":"PHASE4","title":"Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR) (Study P04054)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-08-01","conditions":"Seasonal Allergic Rhinitis","enrollment":728},{"nctId":"NCT00779636","phase":"PHASE4","title":"Effectiveness and Safety of Desloratadine in Patients With Allergic Airway Disease During the Pollen Season (Study P03284)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-07-01","conditions":"Allergic Airway Disease","enrollment":506},{"nctId":"NCT00311844","phase":"PHASE4","title":"A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-03-01","conditions":"Conjunctivitis, Allergic","enrollment":41},{"nctId":"NCT01918033","phase":"PHASE3","title":"A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2013-08-20","conditions":"Perennial Allergic Rhinitis","enrollment":608},{"nctId":"NCT01916980","phase":"PHASE3","title":"Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2013-08-27","conditions":"Eczema, Dermatitis, Dermal Pruritus","enrollment":94},{"nctId":"NCT01916967","phase":"PHASE3","title":"An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2013-08-27","conditions":"Urticaria","enrollment":239},{"nctId":"NCT00536380","phase":"PHASE4","title":"Study for the Treatment of Chronic Idiopathic Urticaria With High Doses of AERIUS (Desloratadine) (Study P04849)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-09","conditions":"Chronic Idiopathic Urticaria","enrollment":314},{"nctId":"NCT00405964","phase":"PHASE3","title":"Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine (Study P04684)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-09","conditions":"Allergic Rhinitis","enrollment":716},{"nctId":"NCT00406783","phase":"PHASE3","title":"Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-08","conditions":"Rhinitis, Allergic, Seasonal, Rhinitis, Allergic, Perennial","enrollment":547},{"nctId":"NCT02320396","phase":"PHASE3","title":"Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2015-01-09","conditions":"Seasonal Allergic Rhinitis","enrollment":449},{"nctId":"NCT06272409","phase":"PHASE3","title":"Efficacy and Safety of DEP114 in the Treatment of Moderate to Severe Persistent Allergic Rhinitis in Children.","status":"NOT_YET_RECRUITING","sponsor":"EMS","startDate":"2025-02-15","conditions":"Allergic Rhinitis","enrollment":318},{"nctId":"NCT06268470","phase":"PHASE2","title":"Antiplatelet Therapy in Chronic Urticaria","status":"UNKNOWN","sponsor":"Chulalongkorn University","startDate":"2018-06-01","conditions":"Chronic Urticaria","enrollment":12},{"nctId":"NCT06217367","phase":"PHASE4","title":"Over-the-Counter Antihistamines & Heat Stress","status":"UNKNOWN","sponsor":"Lakehead University","startDate":"2023-12-05","conditions":"Heat Illness, Allergic Rhinitis, Heat Injury","enrollment":16},{"nctId":"NCT05356143","phase":"PHASE1","title":"A Comparative Study of Rupatadine 10 mg Tablets and Clarinex® 5 mg Tablets Under Fasting Conditions","status":"COMPLETED","sponsor":"J. Uriach and Company","startDate":"2021-12-02","conditions":"Healthy","enrollment":45},{"nctId":"NCT05446480","phase":"NA","title":"Role of Desloratadine in Reducing Inflammation From Occupational Heat Strain","status":"UNKNOWN","sponsor":"University of Victoria","startDate":"2022-07","conditions":"Heat Stress, Exertional, Inflammatory Response, Firefighter Personal Protective Equipment","enrollment":12},{"nctId":"NCT00795522","phase":"PHASE4","title":"An Open-Label Study of the Effects of Desloratadine (Aerius.) Treatment on the Quality of Life of Patients With Chronic Idiopathic Urticaria (Study P02540)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-07","conditions":"Urticaria","enrollment":51},{"nctId":"NCT00794846","phase":"PHASE4","title":"Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03180)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-12","conditions":"Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis","enrollment":124},{"nctId":"NCT00794768","phase":"PHASE4","title":"Preference for Clarinex Tablets vs Allegra Tablets in Patients With Seasonal Allergies (P03178)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-11","conditions":"Seasonal Allergic Rhinitis","enrollment":118},{"nctId":"NCT00805584","phase":"PHASE4","title":"Study of Nasal Symptom Relief and Side Effects in Hayfever Patients Treated With Aerius (Desloratadine)(P03442)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-05","conditions":"Rhinitis, Allergic, Seasonal","enrollment":311},{"nctId":"NCT00795158","phase":"PHASE3","title":"How Desloratadine (Clarinex, Aerius) Affects Quality of Life in Patients With Chronic Idiopathic Urticaria (Have Had Hives for 6 Weeks or Longer)(Study P02988)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-11","conditions":"Urticaria","enrollment":282},{"nctId":"NCT00794599","phase":"PHASE4","title":"Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03182)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-12","conditions":"Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis","enrollment":118},{"nctId":"NCT00794248","phase":"PHASE4","title":"Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03179)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-11","conditions":"Seasonal Allergic Rhinitis","enrollment":122},{"nctId":"NCT00794495","phase":"PHASE4","title":"Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03181)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-12","conditions":"Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis","enrollment":122},{"nctId":"NCT00794794","phase":"PHASE3","title":"Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03826)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-11","conditions":"Allergic Rhinitis","enrollment":204},{"nctId":"NCT00816972","phase":"PHASE2","title":"Desloratadine With Oxybutynin for the Treatment of Seasonal Allergic Rhinitis and Post-Nasal Drip (Study P04258)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-04","conditions":"Post-nasal Drip, Seasonal Allergic Rhinitis, Rhinorrhea","enrollment":540},{"nctId":"NCT00805324","phase":"PHASE3","title":"Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Hayfever With or Without Asthma (P03472)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-05","conditions":"Rhinitis, Allergic, Seasonal, Asthma","enrollment":54},{"nctId":"NCT00817076","phase":"PHASE3","title":"Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Allergic Skin Inflammation (P03475)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-03","conditions":"Dermatitis, Atopic","enrollment":40},{"nctId":"NCT00794378","phase":"PHASE3","title":"Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03829)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-11","conditions":"Allergic Rhinitis","enrollment":202},{"nctId":"NCT00704769","phase":"","title":"Response of Desloratadine Syrup in the Relief of Symptoms Associated With Perennial Allergic Rhinitis in Pediatric Patients (Study P04299)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-05","conditions":"Rhinitis","enrollment":591},{"nctId":"NCT00780403","phase":"PHASE4","title":"Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-08","conditions":"Allergies","enrollment":220},{"nctId":"NCT00359138","phase":"PHASE4","title":"The Duration of the Suppressive Effects of Desloratadine on Allergen Prick Tests After Discontinuation (P04441)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-02","conditions":"Hypersensitivity","enrollment":36},{"nctId":"NCT00779116","phase":"PHASE4","title":"Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-09","conditions":"Allergies","enrollment":217},{"nctId":"NCT00723736","phase":"","title":"Safety of Aerius Syrup in Pediatric Patients Aged 1-5 Years Old With Allergic Rhinitis or Chronic Idiopathic Urticaria (Study P04446AM1)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-12","conditions":"Rhinitis, Urticaria","enrollment":100},{"nctId":"NCT00724698","phase":"","title":"Evaluation of Desloratadine When Used in Patients With Either Allergic Rhinitis or Chronic Idiopathic Urticaria","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-10","conditions":"Rhinitis, Urticaria","enrollment":3011},{"nctId":"NCT00761527","phase":"","title":"Observation of Side Effects and Effectiveness of Desloratadine (Aerius) Syrup in Filipino Children (Study P05634)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-03","conditions":"Rhinitis, Allergic, Seasonal, Rhinitis, Allergic, Perennial, Urticaria","enrollment":2980},{"nctId":"NCT01601522","phase":"PHASE2","title":"Peanut Allergy Oral Immunotherapy Desensitization","status":"COMPLETED","sponsor":"Hamilton Health Sciences Corporation","startDate":"2012-02","conditions":"Peanut Allergy","enrollment":43},{"nctId":"NCT02646020","phase":"PHASE2","title":"Aprepitant vs. Desloratadine in EGFR-TKIs Related Pruritus Treatment","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2015-12","conditions":"Non-small Cell Lung Cancer","enrollment":138},{"nctId":"NCT04399525","phase":"NA","title":"Influence of H1-antihistamines on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin.","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2019-10-28","conditions":"Pruritus","enrollment":12},{"nctId":"NCT04399148","phase":"NA","title":"Influence of Antipruritics on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin.","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2019-06-11","conditions":"Pruritus","enrollment":13},{"nctId":"NCT02904304","phase":"PHASE3","title":"Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/Flu","status":"SUSPENDED","sponsor":"Ache Laboratorios Farmaceuticos S.A.","startDate":"2020-12","conditions":"Cold","enrollment":150},{"nctId":"NCT00866788","phase":"PHASE2","title":"A Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1)","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2009-03","conditions":"Chronic Idiopathic Urticaria","enrollment":90},{"nctId":"NCT01529242","phase":"PHASE3","title":"Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Cutaneous Rash Treatment","status":"TERMINATED","sponsor":"EMS","startDate":"2014-02","conditions":"Cutaneous Hypersensitivity","enrollment":17},{"nctId":"NCT02507635","phase":"PHASE4","title":"Anti-inflammatory H1 Antihistamines Allergic Rhinitis","status":"COMPLETED","sponsor":"Iuliu Hatieganu University of Medicine and Pharmacy","startDate":"2009-02","conditions":"Allergic Rhinitis","enrollment":115},{"nctId":"NCT01985789","phase":"PHASE4","title":"Anti-histamines and Methacholine Challenges.","status":"COMPLETED","sponsor":"Don Cockcroft","startDate":"2013-11","conditions":"Asthma","enrollment":12},{"nctId":"NCT01529229","phase":"PHASE3","title":"Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Persistent Allergic Rhinitis Treatment","status":"COMPLETED","sponsor":"EMS","startDate":"2013-11","conditions":"Allergic Rhinitis","enrollment":210},{"nctId":"NCT01400828","phase":"PHASE3","title":"Investigate the Safety/Tolerability and Efficacy of Bilastine 20mg in Korean Patients With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2011-06","conditions":"Seasonal Allergic Rhinitis","enrollment":239},{"nctId":"NCT01940393","phase":"PHASE4","title":"Evaluation of the Inhibitory Effect of 5 Anti-Histamines in Urticaria","status":"COMPLETED","sponsor":"Grupo de Alergología Clínica y Experimental","startDate":"2013-08","conditions":"Urticaria","enrollment":150},{"nctId":"NCT00521170","phase":"PHASE1","title":"Wheal and Flare Reaction During 24 Hours in Allergic Volunteers.","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2004-11","conditions":"Allergy","enrollment":""},{"nctId":"NCT00160589","phase":"PHASE4","title":"LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis)","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2005-04","conditions":"Rhinitis, Allergic, Perennial","enrollment":729},{"nctId":"NCT00160537","phase":"PHASE4","title":"POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2005-05","conditions":"Seasonal Allergic Rhinitis","enrollment":200},{"nctId":"NCT01720485","phase":"PHASE3","title":"Comparison of Desloratadine Associated With Prednisolone (Tablet)Versus Dexchlorpheniramine Associated With Betamethasone (Tablet) for Adult Persistent Allergic Rhinitis Treatment","status":"UNKNOWN","sponsor":"EMS","startDate":"2013-10","conditions":"Allergic Rhinitis","enrollment":234},{"nctId":"NCT00967967","phase":"NA","title":"Validation of the Rhinitis Control Scoring System (RCSS)","status":"SUSPENDED","sponsor":"Laval University","startDate":"2009-03","conditions":"Asthma, Rhinitis","enrollment":50},{"nctId":"NCT01740284","phase":"PHASE3","title":"A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2008-09","conditions":"Allergic Rhinoconjunctivitis","enrollment":46},{"nctId":"NCT00598611","phase":"PHASE3","title":"Effects of 5 mg vs. 20 mg Desloratadine on Skin Lesions in Patients With Chronic Urticaria (CU)","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2007-09","conditions":"Chronic Urticaria","enrollment":29},{"nctId":"NCT01108783","phase":"PHASE3","title":"A Phase III Efficacy Study of the Symptomatic Treatment of Seasonal Allergic Rhinitis With Bilastine","status":"COMPLETED","sponsor":"Faes Farma, S.A.","startDate":"2003-04","conditions":"Seasonal Allergic Rhinitis","enrollment":720},{"nctId":"NCT01314339","phase":"PHASE1","title":"Bioavailability Study of Dr. Reddy's Desloratadine Tablets, 5 mg Under Fasting Conditions.","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2005-12","conditions":"Fasting","enrollment":28},{"nctId":"NCT00862225","phase":"PHASE2","title":"MOA Study of Ze 339 in Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Max Zeller Soehne AG","startDate":"2008-01","conditions":"Seasonal Allergic Rhinitis","enrollment":18},{"nctId":"NCT01506037","phase":"PHASE1","title":"Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fed Condition","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2006-01","conditions":"Healthy","enrollment":36},{"nctId":"NCT01506791","phase":"PHASE1","title":"Bioequivalence Study of Desloratadine and Pseudoephedrine Extended-release Tablets Under Fed Conditions","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2006-04","conditions":"Healthy","enrollment":44},{"nctId":"NCT01506050","phase":"PHASE1","title":"Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fasting Condition","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2006-01","conditions":"Healthy","enrollment":35},{"nctId":"NCT01444196","phase":"PHASE4","title":"Desloratadine 5, 10 and 20mg in Patients With Cold Urticaria","status":"COMPLETED","sponsor":"Marcus Maurer","startDate":"2009-08","conditions":"Urticaria","enrollment":30},{"nctId":"NCT00264303","phase":"PHASE4","title":"CUTE (Chronic Urticaria Treatment Evaluation)","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2005-12","conditions":"Chronic Idiopathic Urticaria","enrollment":886},{"nctId":"NCT01373138","phase":"PHASE1","title":"Bioequivalence Study of Desloratadine and Pseudoephedrine Sulfate Extended-release Tablets Under Fasting Conditions","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2006-04","conditions":"Healthy","enrollment":34},{"nctId":"NCT01314352","phase":"PHASE1","title":"Bioavailability Study of Desloratadine 5 mg Tablet of Dr. Reddy's Under Fed Conditions","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2005-12","conditions":"Fed","enrollment":28},{"nctId":"NCT00633919","phase":"PHASE2, PHASE3","title":"Efficacy of SLITone in House Dust Mite Allergic Patients","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2006-07","conditions":"Allergy","enrollment":124},{"nctId":"NCT00636870","phase":"PHASE4","title":"Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for Desloratadine","status":"COMPLETED","sponsor":"Sanofi","startDate":"2003-02","conditions":"Allergic Rhinitis","enrollment":220},{"nctId":"NCT00637585","phase":"PHASE4","title":"Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine","status":"COMPLETED","sponsor":"Sanofi","startDate":"2002-12","conditions":"Allergic Rhinitis","enrollment":42},{"nctId":"NCT00600847","phase":"PHASE4","title":"A Study to Assess and Compare the Effects of 5 mg vs. 20 mg Desloratadine on the Development of Cold Urticaria Lesions","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2006-11","conditions":"Acquired Cold Urticaria","enrollment":33},{"nctId":"NCT00424580","phase":"NA","title":"Airway Responses to Montelukast and Desloratadine.","status":"COMPLETED","sponsor":"University of Saskatchewan","startDate":"2007-01","conditions":"Asthma","enrollment":12},{"nctId":"NCT00346606","phase":"PHASE4","title":"The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria","status":"UNKNOWN","sponsor":"Lotus Pharmaceutical","startDate":"2006-01","conditions":"Chronic Idiopathic Urticaria, Urticaria","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["SCH 034117, Clarinex"],"phase":"phase_3","status":"active","brandName":"Desloratadine (Clarinex)","genericName":"Desloratadine (Clarinex)","companyName":"Organon and Co","companyId":"organon-and-co","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Desloratadine is a selective histamine H1-receptor antagonist that blocks histamine-mediated allergic responses without significant central nervous system penetration. Used for Allergic rhinitis (seasonal and perennial), Chronic idiopathic urticaria.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}